Stem cell eye drops show promise for damaged corneas
NCT ID NCT05204329
First seen Jan 31, 2026 · Last updated May 13, 2026 · Updated 12 times
Summary
This early-stage study tested the safety of eye drops made from stem cell secretions (secretome) in 9 adults with chronic corneal damage and reduced eye sensation. The goal was to find the highest safe dose and see if it helps heal the cornea's surface. Participants received increasing doses over time, and doctors monitored eye health using advanced imaging and vision tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL DEFECT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
Conditions
Explore the condition pages connected to this study.